Neurogene
NGNE
NGNE
52 hedge funds and large institutions have $253M invested in Neurogene in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.07% more ownership
Funds ownership: 4.51% → 4.58% (+0.07%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less capital invested
Capital invested by funds: $300M → $253M (-$47.5M)
Holders
52
Holding in Top 10
1
Calls
$208K
Puts
$127K
Top Buyers
| 1 | +$3.82M | |
| 2 | +$1.37M | |
| 3 | +$715K | |
| 4 |
EU
Emory University
Atlanta,
Georgia
|
+$554K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$476K |
Top Sellers
| 1 | -$4.21M | |
| 2 | -$1.78M | |
| 3 | -$339K | |
| 4 |
AP
Archon Partners
Princeton Junction,
New Jersey
|
-$268K |
| 5 |
ProShare Advisors
Bethesda,
Maryland
|
-$188K |